SOUTH SAN FRANCISCO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologics, today announced a business ...

Today, Zacks Equity Research discusses Equity LifeStyle Properties, Inc. ELS and Veris Residential, Inc. VRE. Industry: ...

Jess Miller for Wisconsin Watch, Wisconsin Watch January 8, 2026 This story was produced in partnership with the University ...

Immunocore announces 2026 strategic priorities at 44 th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients with KIMMTRAK (tebentafusp) in 2026 through US ...

While we still love a classic 'flop and drop' holiday, many travellers are choosing to seek experiences with purpose and ...

People who buy health care policies in the Affordable Care Act marketplaces, run by Covered California, are eligible. The ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

Unaudited Total Revenues of Approximately $144.6 Million for First Full Quarter of Launch; Approximately $172.7 Million for ...

A mom’s honest reflection on tiny rituals and gentle beginnings that make January feel lighter, kinder, and more present for ...

COPENHAGEN, Denmark, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today provided a business and strategic roadmap update, including planned 2026 key corporate milestones.

27 Department ofEpidemiology and Preventive Medicine, University of Regensburg, Germany 28 Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia Faculty of ...

Moeve and Galp have reached a non-binding agreement to explore a potential combination of their downstream businesses, with the aim of creating two leading energy platforms in the Iberian Peninsula.